Our offer for corporates

The Pioneer Program

We guide industry leaders coming from and moving into healthcare, offering them corporate foresight, focusing on approaches for their business in next generation healthcare. As part of the corporate foresight process, we constantly screen the global market to identify relevant trends in healthcare, science, tech and other industries. We help our Pioneer Partners construct smart, exact business strategies and new value chains based on our expertise and research. All to shape the future of healthcare.

How we work

We offer a comprehensive execution-based Pioneer Program using our industry knowledge and network.

Our goal is to create innovative value chains for next generation healthcare from corporate foresight to project roll out.


Personal Executive Briefing


Startup Scanner

Network & Experience

Insight Events

Expert Matching

Networking Lounge

Business Strategy

Corporate Foresight Strategy

Projects & Portfolio Management

Corporate Lab

Get in touch

Laura Wamprecht

Director Partner Program

+49 (0) 30 22 05 60 20

F.H. Incubator GmbH
Friedrichstr. 68
10117 Berlin


The AGAPLESION non-profit corporation was founded to strengthen predominantly Christian health institutions in a demanding economic and competitive situation. AGAPLESION includes more than 100 facilities nationwide, including hospitals and care homes, that offer support to more than one million patients per year.


Barmer offers first-class services in private health and nursing insurance and is one of the two largest health insurance companies in Germany, with over 9 million insured.


GWQ Service Plus AG is a services company founded by a corporate health insurance fund. It offers a community platform for medium-sized health insurance companies, for which it develops innovative solutions to improve its members’ business and quality of care. The customers of GWQ represent over 12 million insured in Germany.


medatixx develops solutions for efficient medical practice management and takes a leading position as a provider of ambulance software, MVZ software and software for doctor practices in Germany. In over 21,500 surgeries, MVZ and outpatient clinics, more than 35,000 doctors and approx. 70,000 practitioners work daily with software solutions from medatixx.


Pfizer is the largest pharmaceutical company in the world. For more than 160 years, Pfizer has been developing and driving innovative drugs and vaccines, as well as some of the world's best-known non-prescription products.


As one of the largest private hospital groups in Germany, Sana Kliniken AG is an important provider in the field of integrated health services. Sana provides over 2 million patients in 53 hospitals, offering top medical care across a wide range of services.


Signal Iduna offers a wide range of individual and target group-specific insurances for private customers and corporate clients. Its Health Insurance is one of the five largest private health insurers in Germany.


Teva Pharmaceutical Industries Limited is one of the top 10 pharmaceutical manufacturers worldwide and the world market leader in generic medicines. With Ratiopharm, Teva Germany owns one of the most widely used and well-known pharmaceutical brands in Germany.


The family-owned company Thieme is one of the major providers of books, magazines, electronic media, services and services related to medicine and health as well as the adjacent natural sciences. For many decades the name Thieme has stood for reliable quality and seriousness.


The Unfallkrankenhaus Berlin (UKB) is a highly specialized clinical centre for the treatment of severely ill patients and for the rescue and rehabilitation of severely injured persons with over 600 beds on 20 stations. UKB is divided into 25 specialist areas and provides more than 87,000 patients in Germany every year.


The vfa is the German business association of pharmaceutical companies conducting research. It represents the interests of 42 of the world's leading research-focused pharmaceutical companies and over 100 subsidiaries and affiliates in health, research and economic policy. The members of the VFA represent more than two-thirds of the entire German pharmaceutical market.